MarketPulse

blood test

4 articles
BenzingaBenzinga··Mohd Haider

Onconetix Surges 23% on Proclarix Cancer Test Validation, But Stock Down 99% Annually

Biotech firm $ONCO jumped 23.65% after-hours on clinical progress for prostate cancer blood test, despite 99% annual decline.
LHONCObiotechafter-hours trading
BenzingaBenzinga··Vandana Singh

Roche, Eli Lilly Advance Alzheimer's Screening With CE-Marked Blood Test

Roche and Eli Lilly's blood-based Alzheimer's test Elecsys pTau217 gains European approval, enabling earlier disease detection and potential U.S. FDA clearance later this year.
LLYRHHBYearly detectionAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Roche's New Blood Test for MS Neuroinflammation Gets EU Green Light

Roche receives CE mark for Elecsys NfL blood test detecting neuroinflammation in relapsing-remitting multiple sclerosis, offering minimally invasive alternative to MRI monitoring.
RHHBYmultiple sclerosispatient monitoring
GlobeNewswire Inc.GlobeNewswire Inc.··20/20 Biolabs, Inc.

20/20 BioLabs Posts Strong Growth as Nasdaq Listing, Funding Fuel Expansion

$AIDX reports 17% revenue growth to $2.0M in FY2025, 68% gross profit surge, and 33% net loss improvement following Nasdaq listing and $5M funding round.
IBMAIDXrevenue growthNasdaq listing